Vectors Modes Of Gene Transfer Biology Essay

Fetal cistron therapy is one of the promising fresh scientific schemes to rectify familial upsets. In current scenario, it has been specifically considered to be an auspicious scheme to get the better of the restriction of conventional hematopoietic root cells ( HSC ) therapy by hedging the allogenic HLA barriers, utilizing genetically corrected autologous HSC in fetus.

Vectors ( Modes of Gene Transfer )

By and large vectors used for the cistron bringing to the cells bind specifically to the targeted organ and necessitate merely a individual application. Though the non viral vectors such as cistron gun have been proposed to be safer manner of transduction, but the transgene introduced by them remains episomal or lost with cell division, and therefore renders limited look.

We Will Write a Custom Essay Specifically
For You For Only $13.90/page!

order now

( three ) Hence viral vectors are considered to be more efficient vehicles for cistron bringing due to their ability to perforate host cells and retroflex inside the host cell. Before transfection, they are engineered to rarefy their genome so that merely the transgene, non the viral cistrons are copied. There are several factors like immunogenicity, packing capacity, targeted tissue and coveted continuance of look that drama critical function on the pick of a viral vectors.

( see the book )Past experiments show that Adenoviruss have been used in some of the theoretical accounts of fetal cistron transportation. But they were non found to incorporate into host genome. As a consequence transgene look was found to be instantaneous in quickly spliting fetal cells. Furthermore, their high imunognecity prevented them to be a good vector for in utero cistron therapy.

Adeno associated viruses ( AAV ) are relatively less immunogenic and their serotype influences tissue specificity. But due to their inclination to incorporate into the genome at low frequence and their slow look profile, it may take few hebdomads for AAV to make to top out look degree. Relatively longer continuance of transgene look can be seen in the tissues like cardinal nervous system, liver and skeletal musculuss, where there occurs less turnover of cells. Similarly the vector must incorporate into the host genome in order to guarantee long term look of the transgene.Ideally fetal cistron therapy requires a vector system of specific cistron concept that reach to the needed variety meats and go forth its lasting look avoiding the germ line transmittal. Unfortunately no individual vector is available to run into this end. However due to their capacity to render long term look of cistron, viral vectors like adeno viruses, retro virus and adeno associated viruses are comparatively more suited options for fetal cistron therapy.

( Gregoriadis G. , Mc Cormack B. , 2000 ) .



3.1 Route and Timing

After choice the suited vector, transduction of the targeted population of root cells is carried out, which depends on site of vector administraton and gestational age of the fetus.

Relatively, earlier gestational cistron therapy produce better consequences of transduction of root cells than the ulterior gestation cistron therapy, because root cells applied in earlier gestational life will incorporate into tissue and differentiate along with the growing of the fetus.Transuterine injection guided with ultrasound is the most common manner of antenatal cistron therapy in carnal theoretical accounts. Directadministration into the lung, liver, and encephalon has led to placecistron expression,31-33 whereas vector injected into a organic structure pitsuch as the peritoneal or amnionic pits can potentially transduceseveral different primogenitor cell populations. Developmental phaseat the clip of injection will find which primogenitor cell populationsare exposed to vector and more than one population maybe transduced at a clip. ( 3 ) ( Roybal et al. )

Ex vivo attack

Major concern of ex vivo attack of fetal cistron therapy is to aim autologous hematopoietic root cells in vitro, enabling them to be extremely proliferative and able to give enhanced cistron look. In this attack, the curative cistron is transduced to the autologous HSC in vitro and transplanted back to the fetus.

Give EXAMPLES LIKE SCID ETCECAMPLE:Severe combined immunodeficiency

In vivo attack

In vivo attack of fetal cistron therapy involves the direct transportation of vector cistron concept into the fetus, taking to in vivo transduction of fetal HSC. This technique has the menace of germ line transduction of the cistron. ( Wngner, A.M. , Schoeberlein, A. , Surbek, D, 2009 )

Campaigner diseases

Bing an experimental construct, fetal cistron therapy can presently be targeted for future application in the life endangering monogenic diseases which are caused by absence or inactivation of indispensable cistron merchandise and which manifest themselves in fetal life.

Similarly, holding inclination to do irreversible harm to variety meats in prenatal or early station natal life, is another standard for the campaigner diseases of the fetal cistron therapy. Familial upsets like cystic fibrosis, Phenylketonurea, Haemophilia, Epidermolysis Bullosa, DMD, ADA lack and different hemoglobinopathies are the possible campaigner diseases for fetal cistron therapy. ( Gregoriadis G.

, Mc Cormack B. , 2000 ) .Cystic fibrosis is one of common autosomal recessionary monogenic upset holding incidence of 1 in 2000 in new Borns. ( ADM Jacksin, 1989 the natural history of cystic fibrosis, in: cystic fibrosis ( ed P Goodfellow ) Oxford University Press 1-11 ) . The familial cause behind the oncoming of this disease is the mutant of cistron coding Cystic Fibrosis Transmembrane Regulator ( CFTR ) protein. This disease chiefly affects lungs, pancreas biliary piece of land and bowel, doing shortened anticipation. Appearance of CFTR protein in human embryo occurs by 7 hebdomads of gestation in the yolk pouch and shortly afterwards in ciliated tracheal cells.

This protein is expressed in bowel at 12th hebdomad, and apical sphere of ciliated air passage epithelial tissue in 24th to 25th hebdomad of gestation. ( Ref 5/book ) Thus it shows its critical function during the development of human fetus. Hence cistron therapy in instance of cystic fibrosis is most relevant during prenatal instead than post natal life.Another lung disease caused by lack of surfactant protein B affects the enlargement of neonatal lung after birth. This is another campaigner disease for fetal cistron therapy and can be treated by presenting the cistron encoding this protein, in utero. Similarly, metabolic upsets ( e.g. PKU ) , or storage diseases that occur during antenatal life are other pathological conditions that manifest themselves in fetal life and ideal mark for cistron therapy in utereo.

In the scenario of expensive intervention and jobs associated with perennial transfusions, hemophilia is one of the best illustration of campaigner disease for the application of fetal cistron therapy. Due to the immune responses, station natal cistron therapy does non look to forestall manifestation of hemophilia ( 41/ diary 3 ) . The other factors that make haemophilia an ideal campaigner disease for fetal cistron therapy are: handiness of its antenatal diagnosing, etiology being loss of map of a individual cistron, and its known form of heritage.Haemophilia has been studied extensively in carnal theoretical accounts with the transportation of required cistron at assorted gestational age through different paths utilizing different vectors. Schneider et Al had compared intraperitoneal, intramuscular, and endovenous injections of human factor IX via adeno virus and AAV-2, in E 15.5 fetuss of mice. As a consequence, initial higher degree of factor IX was seen in fetuss transfected with adeno viral vectors.

It was followed by lessening in the look of the transgene in both vectors over clip However, adeno viral vector injected mice maintained the curative degree for sx months. But no antibodies were formed against either vector or transgene. ( 42/3 ) Sabatino et Al. observed low-level human factor IX look after intramuscular injection of AAV-1 and -2 in E14 foetuss and neonatal mice. Tolerance induced to AAV-1 but non AAV-2 allowed the postpartum re-administration of the AAV-1-driven transgene andsubsequent curative factor IX levels.

43/3 The most impressive consequences of antenatal cistron transportation in hemophiliac mice occurred with a lentiviral vector. Waddington et Al. demonstrated curative degrees of factor IX look ( 9-16 % ) for 14 months, improved curdling, and no immune response against the protein following endovenous disposal of a lentiviral-driven transgene into E15 fetuses.

44 These surveies have shown that antenatal cistron therapy in mice can ensue in low-level transgene look that non merely has curative significance, but besides in some instances induces tolerance leting postpartum disposal of the same vector and transgene for sweetening of look.

Experiments on Animal Models and Route of Administration

Fetal cistron therapy has been performed in mice, rats, coneies and sheep so far. Out of them fetal sheep are the most ideal theoretical accounts of fetal cistron therapy because of their physiological and developmental similarities with homos. Using different gnawer theoretical accounts for human familial diseases and assorted paths of disposal, fetal cistron therapy has been aimed to aim different variety meats. However, the theoretical accounts for pre clinical fetal cistron therapy are still under probe. Following paths of disposal can be performed on different carnal theoretical accounts:Intra amnionic bringingSystemic bringing through fetal circulationGene bringing to extra pneumonic tissues in station nidation embryologic experimental animate beings: ( Gene therapy protocols )Most of the current presymptomatic attacks relate fetal cistron therapy with the transduction of fetal heamopoietic tissue.

Many research labs have been successful on to transfect bone marrow cells in civilization. But Problems like length of service of look, trouble on obtaining and transducing totipotant root cells and possible demand of bone marrow extirpation have prompted alternate schemes.Gene transportation to fetal lung:Gene therapy to maturate lung have undergone through [ lenty of clinical tests for the possible therapy against cystic fibrosis.

Respiratory epithelial tissue is the most favorable site for the application of cistron therapy. Following are some of the points that rationalize the application of adenoviral mediated cistron theapy on fetal lung:Limited immune reposnse and minimized inflammatory response on the fetus, protracting the adenovirus mediated transgen look ( 22/new book )Handiness to plentifulness of spliting cells ( may be stem cells ) that allow the usage of ex post facto viral vectors. ( 23/new book )More look of CFTR on fetus than big lungs ( 24, 25/ new book )Less complex surface liner of lungs and presence of limited figure of macrophages and proteins that facilitate the bringing of DNA.Following is the description of adeno-virus mediated cistron transportation protocol in fetal lung. It was carried out by Pitt, Schwarz and Bland in sheep theoretical account.Material and Methods:Production of Retroviral supernant:MFG retro viral vectors inserted with LacZ or secreted human interleukin receptor adversary protein complementary DNA were used.

This MGF vector is the simplified retroviral vector derived from M-MuLV devoiding the polumerase and envelope cistron sequences. However partial joke sequences were tetained to increase the packing efficiency of the unspliced transcript. The inserted complementary DNA were transcribed from the promoter/enhancer sequences from the retroviral long terminal repetition ( LTR ) .High titer amphotrophic manufacturer of recombinant retroviruses were produced by cotransfection of plasmid ( pSV2neo ) into the packaging cells ( CRIP ) . NIH3T3 cells were cultivated in DMEM and provided with 4.5 g/L of glucose and 10 % ( v/v ) heat -inactivated sheep serum, 100 U/ml of penicillin, 200 mg/mL of glutamine, and eventually infected with virus.

The medium incorporating viral supernatant was tested for the viral titer and presence of assistant virus, concentrated 3X and stored at -70degree celcius.Fetal Surgery:Twin fetal lambs were surgically prepared with catheters and the Ewe was sedated intramuscularly with 15 mg/kg Ketalar. After that hysterotomy was performed with halothane and azotic oxide anesthesia. The womb was, so, opened with a little scratch and polyvinyl catheters were placed straight into the fetal carotid arteria, jugular vena and windpipe. Similarly, a fluid- filled catheter was placed in the amnionic pouch, and the catheters were sutured to uterus and venters of Ewe. The lesions were closed with silk suturas, and catheters were placed in a pouch sewn on the wing of the Ewe.

Amniotic pouch was administered with 1000,000 U of penicillin, and 400 milligram of Kantrex during and after surgery. Similarly, fetal vena was administered with 300,000 U of penicillin and 10 milligram of gentamycin at the clip surgery and daily after that. The Ewe was given 5 mL mixture of penicillin and dihydrostreptomycin and 600 milligram of Kantrexs intramuscularly each twenty-four hours.

Administration of Vector to the Fetus:After 1 twenty-four hours of surgery, blood was withdrawn from the carotid arteria catheter for the finding of hematocrit, pH and blood gas tenseness. 60 milliliter of tracheal fluid was withdrawn into a unfertile syringe. After this, 10 mL solution of MFG-viral supernatant holding 3x 10 6 atom per milliliter concentration was brought to room temperature instantly before usage and polybrene was added to a concluding concentration of 2 micro gm per milliliter. The viral supernatant was delivered straight to the tracheal catheter and flushed to the lungs with 30 to 60 milliliter of antecedently withdrawn lung liquid. Same process was carried out for other twin with other MFG-vector. All the catheters were flushed with heparinised saline and antibiotics was given as per the pre defined dose. This whole process was repeated for three back-to-back yearss.Histochemical Techniques:The Ewe and the fetuss were killed with an endovenous overdose of Na Nembutal ( 50 mg/kg ) .

Their lungs were removed and inflated ex vivo to 30 centimeters H20 transpulmonary force per unit area by shooting phosphate buffered solution of pH 7.4 ( incorporating 4 % paraformaldehyde and 0.1 % gluteraldehyde ) .

After that lungs were immersed into phosphate buffered saline incorporating 30 % saccharose and incubated at 4 degree Celsius.For histochemical analysis, little blocks of tissue were obtained from proximal and distal subdivision of each lobe and frozen in liquid N. Frozen subdivisions were cut with cryostat and mounted on poly-L-lysine -coated glass slides.To place beta galactosidase activity, little blocks of fixed tissues were rinsed in PBS and incubated in a solution incorporating 1 mg/mL of 5 bromo 4 chloro 3 indoyl- D-galactopyanoside in Tris-phosphate buffered saline ( pH 8.0 ) in 5mM K ferricyanide and K ferrocyanide. The tissue subdivisions were farther incubated for 8 hours and washed in PBS. After that tissue was frozen and sectioned, followed by counter discoloration with eosin and haematoxylin. The stained subdivisions were observed under microscope.

Similarly, immunohistochemistry was performed on these samples.Consequence:Detectable degrees of beta galactosidase was noted in the upper and lower air passages of some of these animate beings, for 3 hebdomads after infection. Localization of beta galactosidase was found to be the most outstanding in the epithelial cells of proximal air passages with extra histochemical visual aspect associated with fibroblasts and macrophages in the bomber mucous membrane.This experiment was performed utilizing MFG-based replication-defective retroviral vectors to show beta galactosidase and human interleukin receptor adversary protein in the lungs of fetal sheep ( book 2/37 ) . This attack is most applicable to familial disoreders like cystic fibrosis or surfactant apoprotein B lack where possible life clip therapy may be exacted after limited curative application in utero.foetuss and have big foetuss that are conformable to early gestationaluse. In add-on, the ovine immune system hasbeen extensively studied and the ovine life span is long plenty tolet for long-run surveies of safety and efficaciousness. Sheep surveieshave compared different injection techniques and vector types, butmerely low-level look has been reported.

For illustration, injectionof retroviral vectors into preimmune foetal sheep was shown totransduce hematopoetic cells with low-level look observedfor 5 years.38 Intra-tracheal adenoviral and lentiviral injectionshold led to low-level cistron look in peripheral airways.39,40Further research with big carnal theoretical accounts is needed to polish theproficient facets every bit good as the timing of possible foetal cistrontherapy in worlds consequences of antenatal cistron transportation in hemophiliac mice occurred witha lentiviral vector. Waddington et Al. demonstrated curativedegrees of factor IX look ( 9-16 % ) for 14 months, improvedcurdling, and no immune response against the protein followingendovenous disposal of a lentiviral-driven transgene into E15fetuses.44 These surveies have shown that antenatal cistron therapy inmice can ensue in low-level transgene look that non merely hascurative significance, but besides in some instances induces toleranceleting postpartum disposal of the same vector and transgenefor sweetening of look ( 3 )Table: Significant enterprises in the field of fetal cistron therapy in carnal theoretical accounts in metabolic, cardinal nervous system and musculo-skeletal diseases [ Adopted from:




Animal theoretical account




Research worker


1Cystic FibrosisCystic fibrosis transport regulatorMouseAdenovirusIntra-amnioticReversal of the fatal cystic fibrosisLarson et Al.19972Crigler- NajjarUGT 1A1RatLenti virusIntrahepaticDecreased serum hematoidin by 45 % for & A ; gt ; 1 year, but developed antibodiesSeppen20033Pompe ‘s DiseaseGAAMouseAAV-2Intrahepatic, intraperitonealTransduction of the stop with normal contractile map for 6 monthsRucker et Al.

20044Leber ‘s inborn amarosisRPE 65MouseAAV-2SubretinalRestoration of vision for 2.5 months, cistron look for 6 monthsDejneka et Al.20045MPS VII ( Sly syndrome )Beta GlucuronidaseMouseAAV-1IntraventricularCNS look for 1 yearKarolewski et Al20066Duchenne ‘s muscular dystrophyDystrophinMouseAdenovirusIntramuscualrGene look in 2-3 musculuss of injected hind limb, musculus devolution at 9 hebdomadsReay et Al2008( Cystic fibrosis transport regulator: Cystic fibrosis transmembrane conductance regulator, UGT 1A1: UDP-glucuronyl transferase, AAV: Adeno associated virus, RPPE 65: Retinal pigment epithelial tissue 65, MPS VII: Mucopolysaccharidosis VII )Fetal cistron therapy has been performed in mice, rats, coneies and sheep so far. Following paths of disposal can be performed on different carnal theoretical accounts:Intra amnionic bringingSystemic bringing through fetal circulationINCLUDE THE EXAMPLE OF ONE OR TWO EXPERIMENTS ON ANIMALMost of diseases soon treated by cell graftsin the perinatal period are genetically-determined,familial upsets.

It is alluring topropose cistron therapy either postnatally or evenprenatally to these patients.SCID patients with ADA lack have beentreated, ten old ages ago, with ADA cistron therapy exvivo. Using a retroviral vector, the ADA cistron hasbeen transferred to T lymph cells from the patientsand the corrected cells were infused back tothe patients, with a incontrovertible but partialbenefit [ 21 ] . More late, the X-linked SCIDhas been treated by cistron therapy into precursorCD34_ lymph cells of the bone marrow, with amore complete consequence [ 22 ] .

Experimentally, we have observed a larger efficaciousnessof cistron transportation into foetal liver than intobone marrow root cells. Positions of in uteroor neonatal cistron therapy are the undermentioned:ex vivo transportation of the appropriate cistron andvector into foetal cells so in vivo disposalof the cells ( in utero ) ;in vivo direct injection of the appropriate cistronand vector ( in utero ) ;ex vivo transportation of the cistron and vector in cordblood cells at birth, so disposal to thepatient.Particular attention should be devoted to safety and tobar of cistron transportation to germ-line cells. ( 7 )

Commercial facets

Contemporary Scenario

Genteric Inc. , Gene Medicine Inc. , Gen Vec Inc. , etc are some of the pioneering biotechnological companies involved in concern of cistron therapy.

They have been focussed on supplying new coevals cistron therapy and keep the patents of different biotechnological productions.

Future Deductions

Due to some of its virtues over the station natal cistron therapy, fetal cistron therapy shows a batch of possibilities to emerge as a promising field of biotechnology market.

Ethical facets

Safety and possible hazard

Potential hazard of germ line transduction of theraupetic cistron in fetal therapy raises a big figure of societal, legal and moral inquiries. Similarly the possibility of insertional mutagenesis in fetal cells taking to cistron defect or formation of malignant tumor is another facet of fetal cistron therapy that creates ethical job. ( Baronial, R. , Rodeck C.H.

, 2008 ) .At the present clip, there arewell-documented hazards associated with viral vector-mediatedcistron transportation that need to be addressed prior to consideration ofany clinical application in the foetus. However, if safe and effectualmethods for foetal cistron transportation can be developed, a big figureof upsets would be conformable to IUGT. There is an increasingorganic structure of experimental grounds that supports the curativepotency of IUGT. ( 3 )The possible safety concerns of antenatal cistron therapy includethose associated with foetal intercession and those due to cistrontransportation. As with any foetal intercession, foetal loss, infection, andpreterm labour are possible.

In world, a minimally invasive attackutilizing a all right acerate leaf under ultrasound counsel has minimum processrelated morbidity. As antecedently discussed, some cistron transferrelatedhazards depend on the type of vector. The host immune responseto vector or transgene, insertionalmutagenesis caused by incorporatingvectors, and the hazard of a replication-incompetent HIV vectorsgoing replication-competent may all be concerns dependingupon the gestational age of the receiver and the vector conceptused. Common to all vectors used for antenatal cistron transportation are theconcerns of germ-line transmittal, break of normal organdevelopment, and transplacental spread of transgenes to themother.Lentiviral vectors result in efficient transduction because theyintegrate into the host genome, but the DNA interpolation site may holdhurtful effects. New mutants have been observedafter postpartum cistron therapy with integrating vectors. Four instances ofT-cell leukaemia were diagnosed 31-68 months after retroviralmediatedcistron therapy for X-linked SCID.45 Only one prenatal surveyhas demonstrated the same phenomenon.

A high incidence of livertumours was observed in mice that received antenatal injection withan early signifier of third-generation equid infective anaemia virusvectors with self-inactivating constellation. The interpolation siteswere non identified, but no tumours were observed when a similarvector with an HIV anchor was used.46 Further surveies ofprenatally treated animate beings are needed to to the full measure the hazard ofinsertional mutagenesis.Although antenatal cistron transportation has great potency for reconstructingnormal map, use of the foetus may change normal organdevelopment. Both the site of injection and the toxicity of thevector itself need to be evaluated.

Sheep subjected to in-uterointrapulmonary and intracardiac vector injection showed noinauspicious effects on the postpartum bosom and lung development.47However, we have found that fibroblast growing factor 10 lookin the development rat lung leads to cystic adenomatoid deformitiesexemplifying how forced look of a particulartransgene can take to malformation.48Prenatal cistron therapy is directed toward bodily cells, butaccidental cistron transportation to the germ line is a major concern forboth safety and ethical grounds. Targeted cistron therapy that occursafter the compartmentalisation of aboriginal source cells should nonimpact the source line.

49 Gene transportation to the source line has beeninvestigated by several groups. Porada et Al. evaluated sheep thatreceived intraperitoneal retroviral-mediated antenatal cistron transportation.Despite negative genteelness surveies, PCR on the purified spermfrom injected random-access memories and immunohistochemistry of sectioned testiclesshowed low-level transduction of germ cells.

50 More late, thesame group reported that gestational age affects germ cell transduction.Given the likeliness that low-level transduction of sourcecells after systemic disposal of incorporating vector to the foetuscan non be wholly excluded, the frequence of germ-line transduction that is acceptable in the context of intervention ofa terrible familial upset demands to be considered ( 3 )

Foetus as a Patient: Conflict of responsibility

In fetal cistron therapy, there is chance of struggle between the sensed responsibilities and duty of clinician and those of pregnant adult female. Similarly the possible struggle between responsibilities owed by clinician to the pregnant adult females and sensed duty to the well being of the fetus might make ethical jobs. Such state of affairs might originate when the pregnant adult female refuses a curative process that has been recommended by the clinician for the well being of the fetus. ( Baronial, R. , Rodeck C.H.

, 2008 )

Informed Consent and Human Trials

Informed consent is a basic construct of medical research affecting human participants where possible injuries and benefits of the research are exhaustively informed to the participant and they are considered to be the donees of the research. But in fetal cistron therapy, pregnant adult female who is considered to be the participant of the therapy is non the direct donee of the therapy, but her future kid. Since these participants might hold to transport a load of hazard, it might be unethical to enroll them for a therapy that might profit their progeny, until we are unsure about the success of this therapy. ( Baronial, R. , Rodeck C.

H. , 2008 )ELABORATE ALL THE POINTS ON ETHICAL ASPECTSFig Approval procedure of human cistron therapy ( Beginnings: Nichols 1988, Human Gene therapy, National academy of scientific disciplines, page 168


Despite its some of virtues over the station natal cistron therapy, fetal cistron therapy is still under experiment and bears tonss of possible menaces and ethical issues. This technique must undergo a series of tests in suited carnal theoretical accounts to turn out its safety and efficaciousness before originating clinical tests on human existences. Fetal cistron therapy has even greater potency to forestall theoncoming of familial familial diseases, but it is still in the earlyexperimental phase.

Proof-in-principle for foetal cistron therapy formany upsets has already been demonstrated in gnawer and bigcarnal theoretical accounts. Safety concerns affecting the hazard of insertionalmutagenesis, the consequence on organ development and the importanceof low-level source cell transmittal demand to be extensively investigatedin appropriate presymptomatic animate being theoretical accounts prior to applicationin worlds. The moralss of foetal cistron therapy and its possible toalter the human genome besides need to be considered. While greatertissue specificity and safety can probably be accomplished by the usage oftissue-specific boosters, or regulated transgene look, safercistron transportation engineerings will necessitate to be developed to relievethese concerns. ( 3 )Despite the recent progresss in fetal therapy, we are still in demandof a strong grounds of efficaciousness and safety both to the female parent andfetus in many of the exciting curative attacks, perchanceprovided by the consequences of ongoing randomised tests. ( 4 )INCLUDE THE TABLES AND DIAGRAMS100 PERCENT COPY AND PASTE: MENTION SOURCEIF MODIFIED: ADOPTED FROM.

.. … .

.. ..



I'm Ruth!

Would you like to get a custom essay? How about receiving a customized one?

Check it out